Lipofuscin, an endogenous pigment, can be used as a near-infrared fluorescent biomarker to stage and to monitor the progression of chronic liver disease, as shown in mice with induced liver disease and in human livers biopsied from patients with liver fibrosis.
References
Brunt, E. et al. Nat. Rev. Dis. Primers 1, 15080 (2015).
Bugianesi, E. et al. Nat. Rev. Gastroenterol. Hepatol. 15, 11–20 (2018).
Satapathy, S. K. & Sanyal, A. J. Semin. Liver Dis. 35, 221–35 (2015).
Smith, A. D. et al. Hepatology 49, 1017–1044 (2009).
Saif, M. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-0569-y (2020).
Moreno-Garcia, A., Kun, A., Calero, O., Medina, M. & Calero, M. Front. Neurosci. 12, 464 (2018).
Scholten, D., Trebicka, J., Liedtke, R. & Weiskirchen, R. Lab. Anim. 49, 4–11 (2015).
Samir, A. E., Sirlin, C., Grajo, J. R., Dhyani, M. & Li, Q. World J. Hepatol. 10, 530–542 (2018).
Schenker, S., Ali, S. K., Kataria, A. & Malakouti, M. J. Clin. Transl. Hepatol. 5, 394–403 (2017).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
O’Sullivan, J.J., Harder, N.H.O. & Heffern, M.C. Detecting liver disease via an endogenous pigment. Nat Biomed Eng 4, 761–762 (2020). https://doi.org/10.1038/s41551-020-0601-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-020-0601-2
- Springer Nature Limited